| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/19/2001 | CN1313864A Particles of HCV envelope proteins use of vaccination |
| 09/19/2001 | CN1313771A Method for detection of i(legionella) bacteria employing purified antigen-specific antibodies |
| 09/19/2001 | CN1313401A Polypeptide-human space I enzyme 11 and polynucleotide for coding it |
| 09/19/2001 | CN1313393A Polypeptide-human RNA unwindase 13 and polynucleotide for coding it |
| 09/19/2001 | CN1313342A Human testis lactate dehydrogenase A gene coded protein |
| 09/19/2001 | CN1313341A Human testis protein kinase gene coded protein |
| 09/19/2001 | CN1313340A Human sperm-specific protein 2 gene coded protein |
| 09/19/2001 | CN1313339A Human sperm binding gene coded protein |
| 09/19/2001 | CN1313338A Polypeptide motif bound with human CD95 and its polypeptide |
| 09/19/2001 | CN1313336A Polypeptide-jhuman telomeric repetitive sequence bindin 14 and polynucleotide for coding it |
| 09/19/2001 | CN1313335A Polypeptide-human uterin globin 40 and polynucleotide for coding it |
| 09/19/2001 | CN1313332A Polypeptide-human NTF2 associated protein 16 and polynucleotide for coding it |
| 09/19/2001 | CN1313331A Polypeptide-human plasminogen activator inhibitor 2-27 and polynucleotide for coding it |
| 09/19/2001 | CN1313323A Polypeptide-human amyloid glucoprotein 23 and polynucleotide for coding it |
| 09/19/2001 | CN1313318A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313314A Polypeptide-human signal recognition factor 12 and polynucleotide for coding it |
| 09/19/2001 | CN1313313A Polypeptide-human CDC4 analogous protein 12 and polynucleotide for coding it |
| 09/19/2001 | CN1313311A Polypeptide-human NRG3-22 and polynucleotide for coding it |
| 09/19/2001 | CN1313309A Polypeptide-human GAPa protein 9 and polynucleotide for coding it |
| 09/19/2001 | CN1313305A Polypeptide-human guanine intertransform factor 17 and polynucleotide for coding it |
| 09/19/2001 | CN1313303A Polypeptide-human nucleolar phospholation protein P130-17 and polynucleotide for coding it |
| 09/19/2001 | CN1313298A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313297A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313296A Polypeptide-zinc finger protein 62 and polynucleotide for coding it |
| 09/19/2001 | CN1313294A Polypeptide-mTERF-42 and polynucleotide for coding it |
| 09/18/2001 | US6291658 Isolated nucleic acid molecules encoding SSX family members and thereof |
| 09/18/2001 | US6291654 Obtaining protein sample from bacteria, applying to solid support of methylamine treated complement protein c3, washing solid support, and removing c3 binding protein from solid support using alcohol solution |
| 09/18/2001 | US6291652 A monoclonal antibody; therapy for huntington's disease |
| 09/18/2001 | US6291651 A proto-oncogene involved in the development of mesodermal cells from early stage embryonic cells; gene therapy and screening of embryonic defects |
| 09/18/2001 | US6291650 Methods for producing members of specific binding pairs |
| 09/18/2001 | US6291649 Anti-bodies binding adhesin-derived antigens |
| 09/18/2001 | US6291646 A receptor polypeptide having a ligand-binding domain joined to an immunoglobulin constant region; therapy for atherosclerosis, autocrine tumors, fibroplasia and keloid formation |
| 09/18/2001 | US6291643 Apaf-1 an activator of caspase-3 |
| 09/18/2001 | US6291642 Mammalian cell cycle protein |
| 09/18/2001 | US6291641 Hepatitis E virus antigens and uses therefor |
| 09/18/2001 | US6291639 Metal-binding cystein-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds |
| 09/18/2001 | US6291496 Treating cancers associated with overexpression of class I family of receptor tyrosine kinases |
| 09/18/2001 | US6291431 Methods and compositions for the treatment and prevention of Staphylococcal infections |
| 09/18/2001 | US6291430 Mage-3 peptides presented by HLA class II molecules |
| 09/18/2001 | US6291424 Nitrosated and nitrosylated heme proteins |
| 09/18/2001 | US6291242 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 09/18/2001 | US6291239 Immunoglobulin for the treatment and prevention of viral diseases |
| 09/18/2001 | US6291237 Cancer diagnosis and therapy based on mutations in TGF-β receptors |
| 09/18/2001 | US6291235 Nucleotide sequences coding polypeptide for use in the detection, diagnosis and treatment of cancer |
| 09/18/2001 | US6291225 Microorganismal material for use in the treatment, diagnosis and prevention of microorganismal infection |
| 09/18/2001 | US6291218 Identification of eukaryotic growth-related genes and promoter isolation vector and method of use |
| 09/18/2001 | US6291216 Aliphatic hydroxy base bonded to oxirane-containing polymer through thiophilic or metal chelation group ligand; immobilized enzymes; chromatography |
| 09/18/2001 | US6291212 Nucleotide sequences coding polypeptide for the detection and purification of human platelet derived growth factor or isoforms |
| 09/18/2001 | US6291208 Exprsssion vector; for use as diagnostic tools and generating vaccines |
| 09/18/2001 | US6291206 BMP receptor proteins |
| 09/18/2001 | US6291199 Human phosphodiesterase type IVC, and its production and use |
| 09/18/2001 | US6291198 Antibody that recognizes pyrazine derivative and method for measuring 1,2-dicarbonyl derivative using said antibody |
| 09/18/2001 | US6291197 Binding moieties for human parvovirus B19 |
| 09/18/2001 | US6291196 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
| 09/18/2001 | US6291195 Generating ligands which bind preferential human receptors; incubate cells expressing preferential binding protein with modulator, detect adjustment in binding activity |
| 09/18/2001 | US6291183 A plurality of oligonucleotide linker molecules are attached on a planar solid support, photoremovable groups react with terminal ends of oligonucleotides, substrates exposed to light activate binding at selected areas; peptide synthesis |
| 09/18/2001 | US6291161 Method for tapping the immunological repertiore |
| 09/18/2001 | US6291160 Method for producing polymers having a preselected activity |
| 09/18/2001 | US6291159 Isolating catalytic antibodies produced by expression vectors by synthesizing receptor-coding gene libraries containing a plurality of different receptor coding dna sequences, screen the libraries for polypeptides with desires specificity |
| 09/18/2001 | US6291158 Producing vector libraries capable of expressing variable heavy and light chain polypeptides by synthesizing variable chains, amplify and join the variable heavy chain to the light chain into expression vectors and screen the libraries |
| 09/18/2001 | US6291156 Plant pest control |
| 09/18/2001 | US6290970 Transferrin receptor protein of Moraxella |
| 09/18/2001 | US6290962 Urease-based vaccine and treatment for helicobacter infection |
| 09/18/2001 | US6290960 Vaccine and antitoxin for the treatment of C. difficile disease |
| 09/18/2001 | US6290959 Method for screening compounds for inhibiting bacterial attachment to host cell receptors |
| 09/18/2001 | US6290957 Anti-IgE antibodies and method of improving polypeptides |
| 09/18/2001 | US6290955 Antibodies against T cells as therapeutics |
| 09/18/2001 | US6290954 Contacting a source suspected of containing native prpsc with a diagnostically effective amount of an antibody characterized by its ability to bind to native prpsc in situ; and determining whether the antibody binds to any material |
| 09/18/2001 | CA2238879C Thereapeutic applications for the anti-t-bam (cd40-l) monoclonal antibody 5c8 |
| 09/18/2001 | CA2145182C Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 09/18/2001 | CA2079802C Walk-through mutagenesis |
| 09/18/2001 | CA2023894C Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulins |
| 09/18/2001 | CA1341293C Alpha-subunit of the mac-1 leukocyte adhesion receptor |
| 09/18/2001 | CA1341292C The manufacture and expression of consensus human leukocyte interferon |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | WO2001066747A2 Proteins named fctrx and nucleic acids encoding same |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2401552A1 Proteins named fctrx and nucleic acids encoding same |
| 09/13/2001 | WO2001066785A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | WO2001066762A1 Human extracellular signal regulated kinases |
| 09/13/2001 | WO2001066761A1 Inorganic pyrophosphatases from lepidopters |
| 09/13/2001 | WO2001066754A1 Human antibodies against eotaxin and their use |
| 09/13/2001 | WO2001066753A2 Human genes and gene expression products |
| 09/13/2001 | WO2001066746A2 G-protein coupled receptor related polypeptides |
| 09/13/2001 | WO2001066742A2 G-protein coupled receptors |
| 09/13/2001 | WO2001066741A2 Kcnb: a novel potassium channel protein |
| 09/13/2001 | WO2001066740A2 Compositions and methods for the treatment of immune related diseases |
| 09/13/2001 | WO2001066737A1 Polypeptide inducing apoptosis |
| 09/13/2001 | WO2001066736A1 Proteins nectin-3 |
| 09/13/2001 | WO2001066732A1 Human abc transporter expressed in liver, atil |
| 09/13/2001 | WO2001066722A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066716A1 Polypeptide having phosphodiesterase activity |
| 09/13/2001 | WO2001066706A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066595A2 Human fgf-23 gene and gene expression products |
| 09/13/2001 | WO2001066594A2 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | WO2001066563A2 T1r taste receptors and genes encoding same |
| 09/13/2001 | WO2001066557A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066141A1 Remedies and preventives for antiphospholipid antibody syndrome |
| 09/13/2001 | WO2001066140A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/13/2001 | WO2001066139A1 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell |